Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients

Journal of the American Society of Nephrology

Volumn 19, Issue 2, 2008, Pages 405-412

  Ferreira, Aníbal ^a   Frazão, João Miguel ^b   Monier Faugere, Marie Claude ^c   Gil, Célia ^d   Galvao, José ^e   Oliveira, Carlos ^f   Baldaia, Jorge ^g   Rodrigues, Ilidio ^h   Santos, Carla ⁱ   Ribeiro, Silvia ^j   Hoenger, Regula Mueller ^k   Duggal, Ajay ^k   Malluche, Hartmut H ^c,l  

^a HOSPITAL CURRY CABRAL   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF KENTUCKY   (United States)

^d Hospital Vila Franca de Xira   (Portugal)

^e Centro Hospitalar do Oeste   (Portugal)

^f FMC Entrocamento   (Portugal)

^g Unidade de Hemodialise de Guimaraes   (Portugal)

^h Tagus Dial Barreiro   (Portugal)

ⁱ Centro de Hemodialise da Sta Casa da Mesericordia de Vila Verde   (Portugal)

^j HPA Hospital Particular de Almada   (Portugal)

^k Genzyme Europe Research   (United Kingdom)

^l UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; ALUMINUM; AMINO TERMINAL TELOPEPTIDE; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS; SEVELAMER; VITAMIN D;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BICARBONATE BLOOD LEVEL; BONE BIOPSY; BONE MINERALIZATION; BONE TURNOVER; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FRACTURE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; OSSIFICATION; OSTEOID; PARATHYROID HORMONE BLOOD LEVEL; PATIENT COMPLIANCE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL OSTEODYSTROPHY; SIDE EFFECT; THICKNESS; TRABECULAR BONE; TREATMENT OUTCOME;

EID: 39049125268     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2006101089     Document Type: Article

References (26)

1. Monier-Faugere MC, Malluche HH: Trends in renal osteodystrophy: A survey from 1983 to 1995 in a total of 2248 patients. Nephrol Dial Transplant 11[Suppl 3]: 111-120, 1996
2. Couttenye MM, D'Haese PC, Deng JT, Van Hoof VO, Verpooten GA, De Broe ME: High prevalence of adynamic bone disease diagnosed by biochemical markers in a wide sample of the European CAPD population. Nephrol Dial Transplant 12: 2144-2150, 1997
3. Malluche HH, Mawad H, Monier-Faugere MC: The importance of bone health in end-stage renal disease: Out of the frying pan, into the fire? Nephrol Dial Transplant 19[Suppl 1]: i9-i13, 2004
4. Malluche HH, Monier-Faugere MC: Risk of adynamic bone disease in dialyzed patients. Kidney Int Suppl 38: S62-S67, 1992
5. Pei Y, Hercz G, Greenwood C, Segre G, Manuel A, Saiphoo C, Fenton S, Sherrard D: Risk factors for renal osteodystrophy: A multivariant analysis. J Bone Miner Res 10: 149-156, 1995
6. Cannata Andia JB: Adynamic bone and chronic renal failure: An overview. Am J Med Sci 320: 81-84, 2000
7. Chertow GM, Burke SK, Raggi P, Treat to Goal Working Group: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62: 245-252, 2002
8. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC: Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15: 1943-1951, 2004
9. Raggi P, James G, Burke SK, Bommer J, Chasan-Taber S, Holzer H, Braun J, Chertow GM: Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis. J Bone Miner Res 20: 764-772, 2005
10. Asmus HG, Braun J, Krause R, Brunkhorst R, Holzer H, Schulz W, Neumayer HH, Raggi P, Bommer J: Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density. Nephrol Dial Transplant 20: 1653-1661, 2005
11. National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42[Suppl 3]: S1-S201, 2003
12. Martin KJ, Olgaard K, Coburn JW, Coen GM, Fukagawa M, Langman C, Malluche HH, McCarthy JT, Massry SG, Mehls O, Salusky IB, Silver JM, Smogorzewski MT, Slatopolsky EM, McCann L, Bone Turnover Work Group: Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis 43: 558-565, 2004
13. Malluche HH, Faugere MC: Atlas of Mineralized Bone Histology, New York, Karger, 1986
14. Qi Q, Monier-Faugere MC, Geng Z, Malluche HH: Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis 26: 622-631, 1995
15. Hyodo T, Wakai H, Takemura T, Taira T, Hidai H, Tsuchida M, Fujita T, Yoshida K, Baba S, Sakai T: Treatment of adynamic bone disease with the complete replacement from calcium carbonate to sevelamer hydrochloride [in Japanese]. Clin Calcium 15[Suppl 1]: 15-22, 2005
16. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38: 938-942, 2001
17. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18: 1731-1740, 2003
18. Adragao T, Pires A, Lucas C, Birne R, Magalhaes L, Goncalves M, Negrao AP: A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 19: 1480-1488, 2004
19. Taal MW, Roe S, Masud T, Green D, Porter C, Cassidy MJ: Total hip bone mass predicts survival in chronic hemodialysis patients. Kidney Int 63: 1116-1120, 2003
20. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27: 394-401, 1996
21. Shoji T, Nishizawa Y: Vitamin D and survival of hemodialysis patients [in Japanese]. Clin Calcium 14: 64-68, 2004
22. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo CA Jr, Thadhani R: Activated injectable vitamin D and hemodialysis survival: A historical cohort study. J Am Soc Nephrol 16: 1115-1125, 2005
23. Goldner J: A modification of the Masson trichrome technique for routine laboratory purposes. Am J Pathol 14: 237-243, 1938
24. Lillie PD, Fullmer HM: Histopathologic Technique and Practical Histochemistry, 4th Ed., New York, McGraw Hill, 1976
25. Denton J, Freemont AJ, Ball J: Detection of distribution of aluminium in bone. J Clin Pathol 37: 136-142, 1984
26. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche HH, Meunier PJ, Ott SM, Recker RR: Bone histomorphometry: Standardization of nomenclature, symbols, and units. J Bone Miner Res 2: 595-610, 1987